ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
99,231.71
-5.20%
S&P 500
5,985.37
-1.90%
Dow Jones
44,479.80
0.13%
US Dollar vs Yen
154.3385
-1.06%
Brent Oil
75.895
-1.67%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cellectar Biosciences Inc (CLRB)

  7. Cellectar Biosciences Inc (CLRB) ニュース

CLRB

Cellectar Biosciences (CLRB)

Cellectar Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CLRB
日付受信時刻ニュースソース見出しコード企業名
2025/01/1420 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2025/01/1308 : 00GlobeNewswire Inc.Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare ConferenceNASDAQ:CLRBCellectar Biosciences Inc
2024/12/1123 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/12/1107 : 00GlobeNewswire Inc.Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate RestructuringNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1821 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1821 : 05GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1820 : 46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
2024/11/1606 : 33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1506 : 53Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/11/1506 : 47Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/11/1422 : 05GlobeNewswire Inc.Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225NASDAQ:CLRBCellectar Biosciences Inc
2024/11/1406 : 45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1406 : 45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1222 : 05GlobeNewswire Inc.Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of CancerNASDAQ:CLRBCellectar Biosciences Inc
2024/11/1206 : 05GlobeNewswire Inc.Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Monday, November 18, 2024NASDAQ:CLRBCellectar Biosciences Inc
2024/11/0720 : 40GlobeNewswire Inc.Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024NASDAQ:CLRBCellectar Biosciences Inc
2024/11/0206 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/11/0206 : 00GlobeNewswire Inc.Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-QNASDAQ:CLRBCellectar Biosciences Inc
2024/10/3006 : 09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLRBCellectar Biosciences Inc
2024/10/3006 : 03Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/10/3005 : 56Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/08/2619 : 40GlobeNewswire Inc.Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s MacroglobulinemiaNASDAQ:CLRBCellectar Biosciences Inc
2024/08/2406 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/08/2406 : 00GlobeNewswire Inc.Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from NasdaqNASDAQ:CLRBCellectar Biosciences Inc
2024/08/1508 : 15Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CLRBCellectar Biosciences Inc
2024/08/1506 : 00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CLRBCellectar Biosciences Inc
2024/08/1319 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/08/1319 : 40GlobeNewswire Inc.Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate UpdateNASDAQ:CLRBCellectar Biosciences Inc
2024/08/1006 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLRBCellectar Biosciences Inc
2024/08/0906 : 15GlobeNewswire Inc.UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024NASDAQ:CLRBCellectar Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CLRB

最近閲覧した銘柄

COIN
BTCUSD
Bitcoin
AMEX
XLF
Financial Select Sector
USI
USTECH100
US Tech 100
NASDAQ
AMZN
Amazon.com
CCOM
US100
US Tech 100
FX
USDJPY
US Dollar vs Yen
PM
XAUUSD
Gold vs US Dollar
COIN
DOGEUSD
Dogecoin
USOTC
DTEGY
Deutsche Telekom (QX)
SPI
SP500
S&P 500
NYSE
NKE
Nike
COIN
SOLUSD
Solana
NYSE
DIS
Walt Disney
CCOM
SILVER
SILVER
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有